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CT

:   computed tomography

HE

:   hematoxylin and eosin

IQR

:   interquartile range

LUTS

:   lower urinary tract symptoms

MEST

:   mixed epithelial--stromal tumor

MS

:   metastasis

NA

:   not available

NED

:   no evidence of disease

PSA

:   prostate‐specific antigen

RALVP

:   robot‐assisted laparoscopic vesicule prostatectomy

S‐DRE

:   screening digital rectal examination

SV

:   seminal vesicle

Keynote messageA 52‐year‐old man with a MEST originated from the SV underwent RALVP. This is the first case of RALVP performed for MEST of a SV. We report on the surgical technique and pathological findings of the current and previous reported cases of MEST arising from a SV.

Introduction {#iju512157-sec-0005}
============

Primary SV tumors are rare. The most common malignant tumor of the SV is adenocarcinoma, followed by sarcoma and tumors with mixed epithelial and stromal components.[^1^](#iju512157-bib-0001){ref-type="ref"} MEST is a biphasic tumor with stromal and benign epithelial components that was referred to by various terms until the most recent edition of the World Health Organization classification in 2016. However, SV MESTs have rarely been reported.[^1^](#iju512157-bib-0001){ref-type="ref"} We herein report a patient with MEST originating from the right SV who underwent RALVP.

Case presentation {#iju512157-sec-0006}
=================

A 52‐year‐old asymptomatic Asian man was transferred to our hospital for evaluation of a pelvic tumor that was detected incidentally by CT following colon cancer surgery 3 years earlier. Magnetic resonance imaging confirmed a 3.0 × 3.0 × 3.2 cm mass in the middle of the SV, with a thin capsule with contrast‐enhanced irregularities of low and high signal intensities by T1‐ and T2‐weighted imaging, respectively (Fig. [1a](#iju512157-fig-0001){ref-type="fig"}). The tumor was indistinct from the SVs and prostate with no local extension or lymphadenopathy. His serum PSA level was 0.47 ng/mL. Transrectal needle biopsy of the tumor was performed and pathological examination indicated a spindle cell neoplasm, suggesting a possible stromal tumor of uncertain malignant potential on the prostate.

![Pelvic magnetic resonance imaging showed a 3.0 × 3.0 × 3.2 cm solid tumor in the middle of the two SVs with a thin capsule of low‐signal intensity (arrows). The mass was indistinct from the SVs and prostate. Surgical specimen resected by RALVP. (a) T2‐weighted coronal image, (b) T2‐weighted sagittal image. (c) Macroscopically, the tumor was 3.0 × 3.0 × 3.2 cm in diameter and well circumscribed, and arose from the right SV (arrow). The prostate was clearly separated from the tumor. (d) Cross section of a solid tan--white mass centered in the region of the SV. No gross areas of hemorrhage or coagulative necrosis were seen. B, bladder; P, prostate; R, rectum.](IJU5-3-103-g001){#iju512157-fig-0001}

RALVP including tumor resection with bilateral nerve preservation was performed using a four‐arm Da Vinci Si system. During surgery, we initially approached the Douglas pouch to clarify the tumor's environment. After transverse incision of the peritoneum at the level of the pouch of Douglas, the surrounding tissues were carefully released. The peritoneal top of the bladder was then incised again to approach the Retzius space. The tumor became apparent after separating the prostate from the bladder neck. Bilateral neurovascular bundles were spared using the intrafascial approach.[^2^](#iju512157-bib-0002){ref-type="ref"}

There were no intraoperative or postoperative complications. The patient was discharged on postoperative day 8 with normal voiding. There was no CT evidence of disease recurrence within 30 months. The patient wears an occasional pad for safety, but his erectile function has returned and sexual intercourse is possible without phosphodiesterase inhibitors.

Surgical specimen and histopathology {#iju512157-sec-0007}
------------------------------------

Macroscopically, the tumor was well circumscribed and arose from the right SV. The prostate was clearly separated from the tumor. A cross section showed a solid tan--white mass centered in the region of the SV. No gross areas of hemorrhage or coagulative necrosis were seen (Fig. [1a--d](#iju512157-fig-0001){ref-type="fig"}).

Microscopic findings revealed stromal and epithelial tumor components. The stromal component comprised spindle cells with varying degrees of cellularity. Mild nuclear atypia and pleomorphism were focally present (Fig. [2a--d](#iju512157-fig-0002){ref-type="fig"}). These cells showed no evident mitotic activity (\<1/10 high‐power field). The epithelial component comprised dilated, large, lined cuboidal epithelial cells.

![Histological features of surgical specimen. (a) The tumor had stromal and epithelial components (×1.25, HE stain). (b) The stromal component was composed of spindle cells with varying degrees of cellularity (×4, HE stain). (c) Mild nuclear atypia and pleomorphism were focally present (×20, HE stain). (d) The epithelial component was composed of dilated, large, lined, cuboidal epithelial cells (×40, HE stain).](IJU5-3-103-g002){#iju512157-fig-0002}

Immunohistochemically, spindle cells in the stromal component were positive for CD34, estrogen receptor, progesterone receptor, and desmin, but negative for Ki‐67 (\<1%) and p53 (Fig. [3](#iju512157-fig-0003){ref-type="fig"}). The stromal component was positive for AE‐1/3 but negative for PSA and prostatic acid phosphatase. Based on these findings, the pathological diagnosis was low‐grade MEST originating from a SV.

![Immunohistochemical findings of surgical specimen. Stromal component of the tumor was positive for estrogen receptor (weakly), progesterone receptor, CD34, and desmin.](IJU5-3-103-g003){#iju512157-fig-0003}

Discussion {#iju512157-sec-0008}
==========

We report on a middle‐aged man who underwent RALVP for MEST originating from the right SV.

According to the most recent edition of the World Health Organization's classification of Tumors, Pathology and Genetics, MEST including neoplasms previously called "cystadenoma," "epithelial--stromal tumor," "cystomyoma," "cystic epithelial‐stromal tumor," and "mesenchymoma." These tumors were defined as "MEST which are biphasic tumors with stromal and benign epithelial components."[^3^](#iju512157-bib-0003){ref-type="ref"} Pathologically, MEST is classified as low, intermediate, or high grade. Reikie *et al*.[^1^](#iju512157-bib-0001){ref-type="ref"} proposed a distinction of grade based on the histologic characteristics including stromal atypia, mitotic activity, nuclear pleomorphism, and tumor necrosis.

An English‐language PubMed search including 24 reports reviewed by Reikie *et al*. and the current case identified 41 cases of MEST arising from a SV. Excluding one case in which the tumor was detected at autopsy,[^4^](#iju512157-bib-0004){ref-type="ref"} 41 cases reported since 1944 are summarized in Table [1](#iju512157-tbl-0001){ref-type="table"}.

###### 

Summary of published cases of MEST from SV

  Author                  Year   Age (years)   Author\'s terminology               Size (cm)   Symptom   Surgical approach                                Grade                                     Follow‐up (months)   Outcome   
  ----------------------- ------ ------------- ----------------------------------- ----------- --------- ------------------------------------------------ ----------------------------------------- -------------------- --------- ---------------------------------------------
  Plaut *et al*.          1944   66            Cystomyoma                          15          \+        Palpable abdominal mass                          Tumorectomy                               Low                  5         NED
  Soule *et al*.          1951   47            Cystadenoma                         14          \+        LUTS, fatigue                                    NA                                        Low                  300       NED
  Islam *et al*.          1979   37            Mesenchymoma                        5.5         −         S‐DRE                                            Vesiculectomy                             Low                  60        NED
  Lundhus *et al*.        1984   39            Cystadenoma                         9           \+        LUTS, abdominal/perineal pain                    Vesicule‐prostatectomy                    Low                  3         NED
  Mazur *et al*.          1987   49            Cystic epithelial stromal tumor     7           \+        LUTS                                             Tumorectomy                               Intermediate         24        Recurrence, 18 months after final resection
  Bullock *et al*.        1988   59            Cystadenoma                         12          \+        LUTS                                             Vesiculectomy (laparoscopic)              Low                  36        Recurrence, 36 months after final resection
  Raghuveer *et al*.      1989   45            Cystadenoma                         5.5         \+        LUTS, abdominal pain                             Tumorectomy                               Low                  16        NED
  Mazzucchelli *et al*.   1992   63            Cystadenoma                         3           \+        Inguinal pain                                    Vesiculectomy                             Low                  96        NED
  Laurila *et al*.        1992   49            Mullerian adenosarcoma‐like tumor   6           \+        LUTS, palpable abdominal mass                    Cystoprostatectomy                        Intermediate         48        NED
  Ranschaert *et al*.     1992   50            Cystadenoma                         12          \+        LUTS                                             Vesiculectomy                             Low                  −         NA
  Lagalla *et al*.        1993   33            Cystadenoma                         NA          \+        Hematospermia, hematuria                         Tumorectomy                               Low                  −         NA
  Fain *et al*.           1993   61            Cystosarcoma phylloides             8.5         \+        LUTS                                             Cystoprostatectomy                        High                 48        Lung MS, 6 months after chemotherapy
  Peker *et al*.          1997   47            Cystadenoma                         8           \+        Hematospermia, suprapubic discomfort, tenesmus   Vesiculectomy                             Low                  21        NED
  Baschinsky *et al*.     1998   37            Cystadenoma                         6.5         \+        LUTS, hematospermia                              Cystoprostatectomy                        Low                  6         NED
  Santos *et al*.         2001   49            Cystadenoma                         16          \+        LUTS                                             Tumorectomy                               Low                  27        NED
  Abe *et al*.            2002   65            Cystosarcoma phylloides             6           \+        LUTS                                             Vesiculectomy                             High                 11        Lung MS, died 11 months after resection
  Gil *et al*.            2003   49            Cystadenoma                         7           −         S‐DRE                                            Tumorectomy                               Low                  36        NED
  Son *et al*.            2004   39            Phyllodes tumor                     16          \+        LUTS, abdominal pain                             Vesiculectomy                             Intermediate         24        NED
  Lee *et al*.            2006   46            Cystadenoma                         7.5         −         S‐DRE                                            Vesiculectomy                             Low                  6         NED
  Hoshi *et al*.          2006   70            Epithelial stromal tumor            4.6         \+        Abdominal pain, fatigue                          Cystoprostatectomy/ileal neobladder       Low                  14        NED
  Khan *et al*.           2007   43            Phyllodes tumor                     5.5         \+        Hematospermia, testicular pain                   Vesiculectomy (laparoscopic)              Low                  1         NED
  Monica *et al*.         2008   50            Epithelial stromal tumor            9           \+        LUTS, fever                                      Tumorectomy                               Low                  26        NED
  Thway *et al*.          2008   61            Epithelial stromal tumor            8           \+        Hematospermia, suprapubic pain, tenesmus         Vesiculectomy (laparoscopic)              Low                  21        NED
  Lorber *et al*.         2011   52            Cystadenoma                         14          \+        LUTS                                             Vesiculectomy (open)                      Low                  −         NA
  Ploumidis *et al*.      2012   45            Cystadenoma                         17.2        \+        LUTS, pelvic pain                                Vesiculectomy (robot‐assisted)            Low                  −         NA
  Zhu *et al*.            2013   31            Cystadenoma                         8.8         \+        Hematospermia                                    Vesiculectomy (laparoscopic)              Low                  −         NA
  Arora *et al*.          2013   23            Cystadenoma                         NA          \+        LUTS, abdominal pain                             Tumorectomy                               Low                  −         NA
  Zhang *et al*.          2013   32            Cystadenoma                         5           \+        Hematospermia                                    Vesiculectomy (laparoscopic)              Low                  19        NED
  Zhang *et al*.          2013   64            Cystadenoma                         4.5         \+        Perineal pain                                    Vesiculectomy (laparoscopic)              Low                  82        NED
  Zhang *et al*.          2013   50            Adenoma                             3.8         \+        Perineal pain                                    Vesiculectomy (laparoscopic)              Low                  12        NED
  Reikie *et al*.         2015   46            MEST                                4           −         S‐DRE                                            Vesicule‐prostatectomy                    Low                  132       NED
  Reikie *et al*.         2015   60            MEST                                0.5         −         Radical prostatectomy                            Vesicule‐prostatectomy                    Low                  9         NED
  Argun *et al*.          2015   48            Cystadenoma                         6           \+        Diminished ejaculate volume                      Vesiculectomy (robot‐assisted)            Low                  12        NED
  Campi *et al*.          2015   47            Cystadenoma                         7           \+        LUTS                                             Vesiculectomy (robot‐assisted)            Low                  24        NED
  Kuai *et al*.           2017   71            Cystadenoma                         6           −         Ultrasonography                                  Tumorectomy                               Low                  18        NED
  Ameli *et al*.          2017   49            Cystadenoma                         12          \+        LUTS                                             Vesiculectomy (open)                      Low                  −         NA
  Niu *et al*.            2017   59            Cystadenoma                         7.5         \+        LUTS                                             Vesiculectomy (laparoscopic)              Low                  −         NA
  Dong *et al*.           2018   37            Cystadenoma                         11.9        \+        Hematospermia, LUTS, hematuria                   Vesiculectomy (laparoscopic)              Low                  12        NED
  Jaffer *et al*.         2018   32            Cystadenoma                         14          \+        LUTS                                             Vesiculectomy (open)                      Low                  6         NED
  Tang *et al*.           2019   58            Cystadenoma                         55          \+        Hematospermia, LUTS, hematuria                   Vesiculectomy (laparoscopic)              Low                  −         NED
  Current case            2019   52            MEST                                3.2         −         CT                                               Vesicule‐prostatectomy (robot‐assisted)   Low                  51        NED
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The median age of the 41 patients was 49.0 years (IQR 43.0--59.0 years). Many cases were diagnosed as cystadenoma. The median tumor diameter in 39 cases (two cases did not supply the tumor size) was 7.5 cm (IQR 5.5--12.0 cm). The surgical approach depended on the anatomic lesion, tumor size, and surgeon's expertise. Robot‐assisted laparoscopic surgery was performed in recent cases.[^5^](#iju512157-bib-0005){ref-type="ref"}, [^6^](#iju512157-bib-0006){ref-type="ref"}, [^7^](#iju512157-bib-0007){ref-type="ref"}

The median duration of follow‐up for 32 cases after their first surgical approach was 21.0 months (IQR 11.75--39.0 months). The outcome in most cases was "NED." However, two cases had local recurrence diagnosed pathologically as low and intermediate grade, respectively,[^8^](#iju512157-bib-0008){ref-type="ref"}, [^9^](#iju512157-bib-0009){ref-type="ref"} and another two had lung metastases within 48 months, diagnosed as high grade.[^10^](#iju512157-bib-0010){ref-type="ref"}, [^11^](#iju512157-bib-0011){ref-type="ref"} One patient with high‐grade disease died 11 months after metastatectomy.[^10^](#iju512157-bib-0010){ref-type="ref"} These findings suggest that high‐grade MEST requires strict follow‐up after treatment.

The current patient was 52 years old and relatively small size. RALVP including complete tumor resection with bilateral nerve preservation was performed. The patient remained alive with NED recurrence 51 months after surgery. Lober *et al*. reported a patient with a low‐grade tumor who was asymptomatic at the time of diagnosis; however, the tumor increased five‐fold in volume and became symptomatic 10 years later, when surgical removal of the mass was much more difficult.[^12^](#iju512157-bib-0012){ref-type="ref"} Bullock also reported a 12‐cm low‐grade tumor with local recurrence 36 months after treatment due to incomplete resection.[^9^](#iju512157-bib-0009){ref-type="ref"} These cases suggest that the strategy in the current case was appropriate.

Conclusion {#iju512157-sec-0009}
==========

This is the first report of RALVP performed for a MEST of the SV. Long‐term observation is warranted because of a lack of follow‐up evidence to ensure the procedure's safety.
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